T 03101

Drug Profile

T 03101

Alternative Names: T 3101

Latest Information Update: 07 May 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Antigenics; M. D. Anderson Cancer Center
  • Class Antineoplastics
  • Mechanism of Action RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Glioma

Most Recent Events

  • 07 May 1998 Discontinued-Preclinical for Glioma in USA (Unknown route)
  • 20 Feb 1995 Preclinical development for Glioma in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top